The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin
NCT01435655
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Transthyretin Familial Amyloid Polyneuropathy
Interventions
DRUG:
tafamidis
Sponsor
Pfizer